HRT update: therapy may reduce fractures, boost some risks
Researchers review evidence for forthcoming guidelines by the U.S. Preventive Services Task Force.
(HealthDay) -- Updated evidence on hormone replacement therapy for menopausal women presents good news for those at risk of osteoporosis, but a mixed bag of results regarding breast cancer and other chronic diseases.
While estrogen-only and estrogen-plus-progestin formulations reduce the risk of fractures, both increase the odds for stroke and other conditions including gallbladder disease, according to a new update of available evidence compiled for the U.S. Preventive Services Task Force, an independent expert panel that is revising its guidelines.
"We looked at all the published studies on hormone therapy for the prevention of chronic disease," said Dr. Heidi Nelson, who led the update. "What is new here is, we've taken all the results from the last 10 years and tried to distill them into the latest, most current results and how they might apply to individuals."
Some protective effects found in earlier research now appear weaker, added Nelson, a professor of medical informatics, clinical epidemiology and medicine at the Oregon Health & Science University, in Portland. Similarly, some risks look even stronger.
The findings are published online May 29 in the Annals of Internal Medicine.
Years ago, hormone therapy was often prescribed to prevent chronic conditions such as osteoporosis and cardiovascular disease. But initial results of the Women's Health Initiative study, published in 2002, found harmful effects for estrogen-plus-progestin regimens. Two years later, serious alarms were raised about estrogen-only therapy.
As a result, the task force recommended against both types of treatment for prevention of chronic disease.
Now, with about 11 years of follow-up to the Women's Health Initiative, researchers have a fuller picture, which the task force will use to update its existing guidelines.
The recommendations concern only chronic disease, not the use of hormone therapy for reducing symptoms of menopause, such as hot flashes.
For the update, Nelson and her team looked at 51 published articles, involving nine research trials, that met their criteria.
They confirmed that both estrogen alone and combination therapy reduce the risk of fractures, as found before. But they concluded that both types of treatment increase the risk of stroke, blood clots, gallbladder disease and urinary incontinence.
While estrogen alone seems to reduces the risk of breast cancer, they found stronger evidence than before that combination therapy increases the risk for breast cancer. For every 10,000 women, eight more cases of breast cancer per year are expected in those on combination therapy, Nelson said.
Women who smoke, used birth control pills or took combination therapy for symptoms of menopause have higher risks of breast cancer, they found.
Estrogen-only therapy appears to reduce invasive breast cancer by about the same amount, she said, but cautioned that it's not a reason for taking it. This effect is stronger than before, Nelson said.
Other changes: Initial results indicated that those on combination therapy had a significant increased risk for heart disease. Now, that association appears weaker, she said.
Previously, the estrogen-progestin combination was thought to protect against colon cancer. That link also looks weaker, she said.
Nelson said the differences in risks and benefits are probably explained more by the risk profiles of the women who take each therapy rather than the progestin or its lack in the therapy itself. The women have different risk factors to begin with, she said. For instance, many taking only estrogen have had a hysterectomy, with their uterus and ovaries removed, she said.
Bottom line? It does not appear wise to take hormone therapy long-term to prevent chronic conditions, she said. The best strategy remains to take the therapy, if needed for symptoms, at the lowest dose for the shortest time possible.
Given the different risks associated with estrogen-only and combination therapy, it's important to discuss your individual health history with your doctor, experts said.
Dr. Jill Rabin, chief of ambulatory care, obstetrics and gynecology at Long Island Jewish Medical Center, in New Hyde Park, N.Y., agreed that short-term, low-dose therapy for relief of symptoms is the best strategy.
Another option, she tells her patients, is to "think local." Some women are helped by estrogen cream or estrogen vaginal rings, she said.
More information: To learn more about hormone therapy, visit the U.S. National Institutes of Health.
Journal reference: Annals of Internal Medicine
Copyright © 2012 HealthDay. All rights reserved.
- Combo hormone therapy has increased breast cancer risk over estrogen alone Nov 18, 2011 | not rated yet | 0
- Menopausal hormone therapy and breast cancer risk Mar 15, 2012 | not rated yet | 0
- Blood cholesterol levels predict risk of heart disease due to hormone therapy May 23, 2008 | not rated yet | 0
- Hormone therapy raises cancer risk Jan 16, 2008 | not rated yet | 0
- Breast tenderness in women getting combo hormone therapy associated with increase in breast density Oct 14, 2011 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Pressure-volume curve: Elastic Recoil Pressure don't make sense
7 hours ago From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
23 hours ago I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013 As an experiment, for the past few months I've been consuming at least one portion of Jell-O or unflavored Knox gelatin per day. I'm 64, in very...
Alcohol and acetaminophen
May 13, 2013 Edit: sorry for the typo in the title , can't edit I looked around on google quite a bit and it's very hard to find precise information on the...
Marie Curie's leukemia
May 13, 2013 Does anyone know what might be the cause of Marie Curie's cancer
- More from Physics Forums - Medical Sciences
More news stories
In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as ...
Medical research 18 hours ago | 3.7 / 5 (3) | 0 |
Scientists investigating the interaction of a group of proteins in the brain responsible for protecting nerve cells from damage have identified a new target that could increase cell survival.
Medical research 23 hours ago | 5 / 5 (1) | 0
New findings by researchers carrying out experiments at the U.S. Department of Energy Office of Science's Advanced Photon Source (APS) help explain why some drugs that interact with two kinds of human serotonin ...
Medical research May 17, 2013 | not rated yet | 0 |
Peptide molecules derived from the body's natural immune system can help boost the body's defence against life-threatening blood poisoning, joint University research has uncovered.
Medical research May 17, 2013 | 4 / 5 (1) | 0 |
A new Montréal study conducted by Dr. May Faraj, associate research professor at the Université de Montréal and invited scientist at the IRCM, along with her research team and medical collaborators, shows ...
Medical research May 17, 2013 | not rated yet | 0 |
An increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week (DDW).
24 minutes ago | not rated yet | 0 |
A ground-breaking advance in colonoscopy technology signals the future of colorectal care, according to research presented today at Digestive Disease Week(DDW). Additional research focuses on optimizing the minimal withdrawal ...
22 minutes ago | not rated yet | 0
Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.
8 hours ago | 5 / 5 (1) | 0
For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests
Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or ...
9 hours ago | not rated yet | 0 |
(Medical Xpress)—What if the quality of your work depends more on your focus on the piano keys or canvas or laptop than your musical or painting or computing skills? If target users can be convinced, they ...
21 hours ago | 3.7 / 5 (3) | 0 |
The neural machinery underlying our olfactory sense continues to be an enigma for neuroscience. A recent review in Neuron seeks to expand traditional ideas about how neurons in the olfactory bulb might encode information about ...
20 hours ago | not rated yet | 0 |